Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Tranexamic acid
Medication labelCYKLOKAPRON® is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need…
Why this: Advisory · dailymed-prescription
CYKLOKAPRON® is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
- generic_name
- tranexamic acid
- product_names
- tranexamic acid
- ndc
- 0013-1114, 0013-1114-01, 0013-1114-10, 0013-1114-20, 0013-1114-21, 0013-1114-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en